BioDuro, CRDMO which has seven sites across the USA and China, has announced the opening of a fully-automated solid-phase peptide synthesis scale-up laboratory at its Shanghai Zhangjiang High-tech Park campus in China.

The new facility, which houses automated solid-phase peptide synthesisers, cleavage systems and freeze-drying equipment which supports peptide synthesis scale-up to 800 mmol, is intended to enable a wide range of peptide molecules such as peptide drug conjugates, cyclic and linear peptides to be processed.